In-hospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischaemic stroke

摘要

Background. Thrombolytic therapy is an effective treatment modality for acute ischaemic stroke within 3 hours of symptom onset. Its safety and efficacy have not been studied in patients with chronic kidney disease (CKD), who are known to have abnormalities in coagulation and platelet function.